As of Nov 2, 2026: Michael S. Weiss (CEO, TGTX) reported no shares bought or sold themselves in the last 12 months (Form 4). TGTX's Quality Score is 21. Scores as of 3:51 PM ET, 15 minutes behind.

Michael S. Weiss

CEO of TG Therapeutics

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Jan 8: stock award (622,000 TGTX shares).

Bought$012 months Sold$012 months Last filedJan 8stock award

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Michael S. Weiss reported

None in the last 12 months, as filed.

Their filings on the SEC's siteEvery Form 4 they filed, as filed, on EDGAR.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See TGTX's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Michael S. Weiss' companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
TGTXTG TherapeuticsCEO	CEOfiled Jan 9	0	21

Alerts for Michael S. Weiss

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Jan 8, 2026.

Free to reuse with a link to this page.

How to cite

Breakaway, Michael S. Weiss: CEO at TG Therapeutics (TGTX), Jan 8, 2026, getbreakaway.com/insiders/michael-s-weiss

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at TG Therapeutics

Insider trades by person